LONDON, July 9 (Reuters) - European regulators are launching a new probe into the safety of GlaxoSmithKline Plc’s (GSK.L) diabetes pill Avandia, adding to pressure on a medicine that already faces a grilling from U.S. experts next week.
LONDON, July 9 (Reuters) - European regulators are launching a new probe into the safety of GlaxoSmithKline Plc’s (GSK.L) diabetes pill Avandia, adding to pressure on a medicine that already faces a grilling from U.S. experts next week.
